By LSE RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
|
|
|
|||
1. Identity of the issuer or the underlying issuer |
BioPharma Credit PLC |
|||
2. Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
|
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
|
|||
Other (please specify): Placing of New Shares |
|
x |
||
3. Full name of person(s) subject to the |
Prudential plc group of companies
|
|||
4. Full name of shareholder(s) |
Prudential plc The Prudential Assurance Company Limited M&G Group Limited M&G Limited M&G Investment Management Limited
|
|||
5. Date of the transaction and date on |
27 March 2017 |
|||
6. Date on which issuer notified: |
28 March 2017 |
|||
7. Threshold(s) that is/are crossed or |
20% |
|||
8. Notified details: |
|||||||||||||||
A: Voting rights attached to shares |
|||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
|||||||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||||||||||
ORD USD0.01 GB00BDGKMY29 |
Below 5% |
Below 5% |
109,000,000 |
0 |
109,000,000 |
0 |
20.69% |
||||||||
|
|||||||||||||||
B: Qualifying Financial Instruments |
|||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|||||||||||
|
|
|
|
|
|||||||||||
|
|||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
|||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||
Type of financial |
Exercise price |
Expiration date |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights
|
||||||||||
|
|
|
|
|
Nominal |
Delta |
|||||||||
|
|
||||||||||||||
|
|||||||||||||||
Total (A+B+C) |
|||||||||||||||
Number of voting rights |
Percentage of voting rights |
||||||||||||||
109,000,000 |
20.69% |
||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
Prudential plc (parent Company) - 109,000,000 (20.69%) The Prudential Assurance Company Limited (wholly owned subsidiary of Prudential plc) - 104,665,724 (19.87%) M&G Group Limited (wholly owned subsidiary of Prudential plc) - 109,000,000 (20.69%) M&G Limited (wholly owned subsidiary of M&G Group Limited) - 109,000,000 (20.69%) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) - 109,000,000 (20.69%)
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
N/A |
|
11. Number of voting rights proxy holder will cease |
N/A |
|
12. Date on which proxy holder will cease to hold |
N/A |
|
|
||
|
|
|
14. Contact name: |
John Baker / Owen Smith / James Todd M&G Investment Management Limited |
|
15. Contact telephone number: |
020 7548 2561 / 020 7004 4517 / 020 7548 2293 |
|
You are here: news > regulatory news